• Screening MMV Compounds Against MDR Bacterial and Fungal Pat

  2026-08-04

  This study systematically screened Pandemic Response Box compounds against multidrug-resistant (MDR) clinical isolates of Acinetobacter baumannii, Pseudomonas aeruginosa, Candida auris, and Candida albicans. The findings highlight several candidate molecules with potent activity against drug-resistant fungi and bacteria, emphasizing the ongoing need for novel antimicrobial development.

• PA-824: Bicyclic Nitroimidazole Derivative for TB Research S

  2026-08-04

  PA-824 accelerates tuberculosis research with robust, dual-action efficacy against both drug-sensitive and drug-resistant Mycobacterium tuberculosis. Explore advanced workflows, protocol enhancements, and troubleshooting strategies that maximize experimental reproducibility and translational impact.

• Syringin Sensitizes RCC to Sunitinib via EGFR/PI3K/Akt Inhib

  2026-08-03

  This study demonstrates that Syringin, a natural product, inhibits renal cell carcinoma (RCC) cell growth and enhances sensitivity to sunitinib by targeting the EGFR/PI3K/Akt pathway. The findings provide a mechanistic rationale for using Syringin to overcome drug resistance in RCC and inform the design of combination treatment regimens.

• Practical Use of HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L)

  2026-08-03

  The HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody enables sensitive, specific fluorescent detection of rabbit primary antibodies in immunofluorescence, microscopy, and flow cytometry. It should be avoided in protocols that require detection of non-rabbit primaries, direct conjugation to other labels, or are incompatible with sodium azide.

• Olsalazine Sodium: Molecular Insights and Advanced Research

  2026-08-02

  Discover the multifaceted role of Olsalazine Sodium as a mesalamine dimer in inflammation and cancer research. This article offers a deep dive into its molecular mechanisms, unique transport dynamics, and how new findings can refine experimental assays.

• Perphenazine in Translational Research: Mechanisms and New F

  2026-08-01

  Explore Perphenazine’s emerging roles in neuropharmacology and host-pathogen research, from dopamine D2 antagonism to mitochondria-mediated cell death and macrophage immune modulation. This thought-leadership article synthesizes mechanistic insights, recent evidence, and actionable strategies for translational researchers, highlighting APExBIO’s high-purity Perphenazine as a versatile tool for advanced workflows.

• Bifendate (DDB): Multiomics Insights and Practical Hepatopro

  2026-07-31

  Discover how Bifendate (DDB) acts as a powerful hepatoprotective agent through multiomics-driven insights and unique regulatory pathways. This article reveals how advanced molecular profiling elevates DDB's application in liver research, offering a fresh perspective beyond standard protocol guides.

• L-Glutathione Reduced: Precision Redox Modulation in Cancer

  2026-07-31

  L-Glutathione Reduced from APExBIO empowers researchers to dissect redox balance and metabolic vulnerabilities in cancer cells, with particular strength in oxidative stress and GST-affinity applications. This article delivers actionable workflows, protocol enhancements, and troubleshooting strategies tailored for high-impact translational research.

• Lambda Protein Phosphatase: Precision Tools for Phosphorylat

  2026-07-30

  Lambda Protein Phosphatase (RNase-free) from APExBIO stands out as a dual-specificity enzyme for dissecting protein phosphorylation, excelling in workflows that demand validation of phospho-specific antibodies and site-specific dephosphorylation. Its robust performance and protocol versatility make it an indispensable tool for researchers interrogating post-translational regulation in circadian biology and beyond.

• Redefining Low-Abundance Protein Detection in Retinal I/R Mo

  2026-07-30

  This thought-leadership article explores how hypersensitive ECL chemiluminescence advances immunoblotting detection of low-abundance proteins, with strategic insights for translational researchers studying retinal ischemia-reperfusion (I/R) injury. By bridging mechanistic understanding with experimental innovation, we highlight the pivotal role of ultra-sensitive protein detection—using APExBIO's ECL Chemiluminescent Substrate Detection Kit (Hypersensitive)—in dissecting the molecular events driving retinal neuron apoptosis and oxidative stress.

• Fluorescein TSA Fluorescence System Kit: Unmatched Sensitivi

  2026-07-29

  The Fluorescein TSA Fluorescence System Kit delivers breakthrough sensitivity for detecting low-abundance biomolecules in IHC, ICC, and ISH. Its optimized tyramide signal amplification workflow empowers researchers to visualize minute protein or nucleic acid targets with precision, outperforming conventional fluorescence detection.

• Annexin V-Cy5 Apoptosis Kit: Precision Detection in Neuroimm

  2026-07-29

  The Annexin V-Cy5 Apoptosis Kit enables rapid, sensitive detection of apoptosis by targeting phosphatidylserine exposure. This article outlines the biological rationale, mechanism, and benchmarked performance of the kit in neuroimmune research, including its application in lysosomal stress models.

• hiPSC-Derived Intestinal Organoids for Pharmacokinetic Model

  2026-07-28

  This study introduces a streamlined protocol for generating human induced pluripotent stem cell (hiPSC)-derived intestinal organoids, providing a more physiologically relevant in vitro model for pharmacokinetic and drug metabolism research. The findings improve upon current models, offering enhanced self-renewal, differentiation capacity, and practical advantages for drug absorption and metabolism studies.

• K⁺ Channel Blockade Reduces Renal Perfusion in Septic Rats

  2026-07-28

  This study demonstrates that blocking ATP-sensitive and calcium-activated potassium channels exacerbates reductions in renal blood flow when vasoactive agents are administered to septic rats. The findings reveal a critical role for K⁺ channels in maintaining renal vascular function during sepsis, with implications for both vascular biology and translational research on vasodilation pathways.

• ICAA Regulates RIP3 to Counteract Angiotensin II Cardiac Hyp

  2026-07-27

  The reference study demonstrates that isochlorogenic acid A (ICAA) directly targets RIP3 to inhibit its phosphorylation, thereby attenuating angiotensin II-induced cardiac hypertrophy both in vitro and in vivo. These findings introduce the RIP3/CaMKII axis as a novel therapeutic target, with implications for future cardiovascular disease research.

16491 records 1/1100 page Next 12345 下5页 Last page